Euphorbia resinifera (Euphorbia resinifera): Benefits, Dosage, Safety & Evidence

Questions fréquentes

How does Euphorbia resinifera work for pain relief?

Euphorbia resinifera contains resiniferatoxin, an ultra-potent agonist of the TRPV1 (transient receptor potential vanilloid 1) ion channel. When applied, resiniferatoxin initially activates TRPV1 receptors, causing a brief burning sensation, followed by prolonged desensitization of pain-sensing neurons. This effectively silences pain signaling without affecting other sensory functions like touch or vibration. Research indicates this mechanism is similar to capsaicin but approximately 1,000 times more potent, making it a promising candidate for treating severe chronic pain conditions (Evidence Level C).

Does Euphorbia resinifera interact with any medications?

There is limited clinical data on drug interactions for Euphorbia resinifera. Due to its potent effects on TRPV1 receptors and significant toxicity profile, it should not be combined with other topical analgesics, capsaicin products, or medications affecting nerve signaling. The plant's latex contains irritating diterpenoids that may alter skin absorption of other substances. Given its experimental status and lack of approved therapeutic applications, formal drug interaction studies in humans have not been conducted (Evidence Level D).

What is the recommended dosage of Euphorbia resinifera?

There is no established safe or recommended dosage for Euphorbia resinifera for self-medication. This plant is currently restricted to experimental research settings under strict medical supervision. The active compound resiniferatoxin is being investigated at microgram doses for potential clinical applications in treating severe chronic pain. Internal use and unsupervised topical application are strongly contraindicated due to risks of severe tissue damage and systemic toxicity. Patients should never attempt self-medication with this herb (Evidence Level C).

Is Euphorbia resinifera safe during pregnancy and breastfeeding?

Euphorbia resinifera is considered unsafe during pregnancy and breastfeeding. The plant's latex contains potent diterpenoids and toxic compounds that can cause severe irritation, tissue damage, and systemic toxicity. These compounds may cross the placenta or pass into breast milk, potentially harming fetal development or the nursing infant. Historical use never included pregnant populations. Due to significant toxicity risks and lack of safety data, pregnant and breastfeeding women should avoid all contact with this plant (Evidence Level D).

What are the side effects of Euphorbia resinifera?

Euphorbia resinifera can cause severe skin and mucous membrane irritation, including intense burning, redness, blistering, and potential tissue damage upon contact with the latex. Internal exposure may result in severe gastrointestinal distress, inflammation of mucous membranes, and systemic toxicity affecting multiple organ systems. The irritant compounds are highly concentrated in the plant's milky latex. Even minimal skin contact can produce significant adverse reactions. Due to these serious safety concerns, the plant is not appropriate for self-medication (Evidence Level C).

Fiche d'information compilée à partir de PubMed

Cette fiche a été compilée à partir de résumés PubMed (NIH) avec l'assistance d'une IA. Chaque affirmation factuelle est citée par un article PubMed réel (voir la liste des sources). Elle n'a pas encore été révisée par un humain — confirmez auprès d'un professionnel de santé avant utilisation.

Compilé à partir de 30 articles PubMed · modèle : gemma4:31b

Résumé

Euphorbia resinifera is a Moroccan endemic shrub known for its medicinal latex and honey, containing potent compounds like resiniferatoxin [PMID: 38295538, 38005743].

Contexte

Euphorbia resinifera O. Berg is a prickly, leafless, succulent shrub endemic to the Northern and Central regions of Morocco [PMID: 38295538, 39319978]. It is characterized by the secretion of a poisonous latex and the production of monofloral honey from its pseudo-inflorescences (cyathia) [PMID: 38295538].

Usages traditionnels

Historically used in Moroccan medicine for various health issues including cancer [PMID: 38987732]. In Northern Africa, cyathium-derived products are used as ointments and water decoctions [PMID: 38295538]. It has been used by Roman doctors for joint pain, in Chinese folk medicine for damp-cold or mucous diseases such as arthralgia and ascites, and in northeastern Brazil for rheumatoid arthritis and skin tumors [PMID: 36610673, 9064473].

Composés actifs

The plant contains resiniferatoxin [PMID: 38295538], 12-deoxyphorbol esters [PMID: 38005743, 6746723], various triterpenoids (including euphane and tirucallane types) [PMID: 26586618, 30384534, 34581047], and a serine protease designated as EuRP-61 [PMID: 31678105]. Phenolic compounds such as catechol and protocatechuic acid have also been identified in the latex [PMID: 36014466].

Mécanisme d'action

Resiniferatoxin interacts with the vanilloid receptor on primary sensory neurons to modulate pain perception [PMID: 9064473]. Diterpenes from the genus regulate the protein kinase C (PKC) family to promote neural precursor cell proliferation [PMID: 38005743]. The protease EuRP-61 hydrolyzes human fibrinogen and inhibits platelet aggregation via the ADP-receptor pathway [PMID: 32781033, 31678105]. Total triterpenes (TTE) may improve arthritis through PI3K/AKT/Bax and NF-κB/NLRP3 signaling pathways [PMID: 36610673].

Preuves cliniques

Preuve CPain (Osteoarthritis, Neuropathic pain)

Resiniferatoxin has pain-relieving activity superior to capsaicin and is effective for treating osteoarthritis [PMID: 39977586]; clinical trials for diabetic polyneuropathy and postherpetic neuralgia have been pursued [PMID: 9064473].

Preuve DColon Cancer

Extracts of E. resinifera inhibit colon cancer cell lines (DLD-1) by affecting apoptosis, migration, and proliferation [PMID: 38987732].

Preuve DRheumatoid Arthritis

Total triterpenes (TTE) from Euphorbium showed preventive effects against FCA-induced arthritis in rats [PMID: 36610673].

Preuve DThrombosis/Coagulation

The protease EuRP-61 prolongs prothrombin (PT) and activated partial thromboplastin (APTT) times and hydrolyzes fibrin clots [PMID: 32781033].

Sécurité et effets indésirables

The latex is poisonous and contains extremely skin-irritant and moderately tumor-promoting diterpene esters [PMID: 38295538, 6746723]. Exposure to resiniferatoxin has been reported to cause corneal edema [PMID: 30950895].

Synthèse des preuves

The evidence is primarily preclinical (in vitro cell lines and in vivo animal models) or based on chemical characterization, with some historical and review-level data on clinical pain management. No high-level human clinical trials (Level A or B) were provided in the abstracts.

Sources PubMed

1.PMID: 38534665 (2024) — Chemical Characterization and Biological Properties Assessment of Euphorbia resinifera and Euphorbia officinarum Moroccan Propolis. · Antibiotics (Basel, Switzerland)
2.PMID: 38987732 (2024) — Two spurge species, Euphorbia resinifera O. Berg and Euphorbia officinarum subsp. echinus (Hook.f. & Coss.) Vindt inhibit colon cancer. · BMC complementary medicine and therapies
3.PMID: 38295538 (2024) — Biochemical characterization of Euphorbia resinifera floral cyathia. · Journal of plant physiology
4.PMID: 36014466 (2022) — Antifungal and Cytotoxic Activity of Diterpenes and Bisnorsesquiterpenoides from the Latex of Euphorbia resinifera Berg. · Molecules (Basel, Switzerland)
5.PMID: 6746723 (1984) — On the active principles of the spurge family (Euphorbiaceae). V. Extremely skin-irritant and moderately tumor-promoting diterpene esters from Euphorbia resinifera Berg.

Euphorbia resinifera

Sources et citations

Calculer une dose sûre de Euphorbia resinifera